PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.\', \'Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar.\', \'Communicable Disease Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar. Electronic address: aomrani@hamad.qa.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00422-710.1016/j.ijid.2021.05.021
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33992763
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • The initial impact of a national BNT162b2 mRNA COVID-19 vaccine rollout.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all